American Journal of Kidney Diseases
Volume 50, Issue 5 , Pages 721-732 , November 2007

Sequence of Progression of Albuminuria and Decreased GFR in Persons With Type 1 Diabetes: A Cohort Study

  • Tina Costacou, PhD

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
    • ,
  • Demetrius Ellis, MD

      Affiliations

    • Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA
    • ,
  • Linda Fried, MD, MPH

      Affiliations

    • Veterans Pittsburgh Health Care System of Pittsburgh, Pittsburgh, PA
    • Department of Medicine, Renal Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA.
    • ,
  • Trevor J. Orchard, MBBCh, MMedSci

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
    • Corresponding Author InformationAddress correspondence to Trevor J. Orchard, MD, University of Pittsburgh, Diabetes and Lipid Research Bldg, 3512 Fifth Ave, Pittsburgh, PA 15213.

Received 26 January 2007 ,Accepted 7 August 2007.

References 

  1. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006;55:1832–1839
  2. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289:3273–3277
  3. Molitch ME, Rutledge B, Steffes M, Cleary P. Renal insufficiency in the absence of albuminuria among adults with type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes. 2006;55(suppl 1):S6A;abstr
  4. Centers for Disease Control and Prevention (CDC). Incidence of end-stage renal disease among persons with diabetes—United States, 1990-2002. MMWR Morb Mortal Wkly Rep. 2005;54:1097–1100
  5. Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications of IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990;39:1116–1124
  6. Orchard TJ, Dorman JS, Maser RE, et al. Factors associated with the avoidance of severe complications after 25 years of insulin dependent diabetes mellitus: Pittsburgh Epidemiology of Diabetes Complications Study–I. Diabetes Care. 1990;13:741–747
  7. Wagener DK, Sacks JM, LaPorte RE, McGregor JM. The Pittsburgh Study of insulin-dependent diabetes mellitus: Risk for diabetes among relatives of IDDM. Diabetes. 1982;31:136–144
  8. Borhani NO, Kass EH, Langford HG, Payne GH, Remington RD, Stamler J. The hypertension detection and follow-up program. Prev Med. 1976;5:207–215
  9. Warnick GR, Albers JJ. Heparin-Mn2+ quantitation of high density lipoprotein cholesterol: An ultrafiltration procedure for lipemic samples. Clin Chem. 1978;24:900–904
  10. National Institutes of Health, Department of Health Education and Welfare. Lipid Research Clinics Program. Washington, DC: US Government Printing Office; 1975;
  11. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–475
  12. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476–482
  13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  14. Williams KV, Erbey JR, Becker DJ, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes?. Diabetes. 2000;49:626–632
  15. Ellis D, Buffone GJ. A new approach to the evaluation of proteinuric states. Clin Chem. 1977;23:666–670
  16. Ellis D, Coonrod BA, Dorman JS, et al. Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis. 1989;4:321–328
  17. Assadi FK, John EG, Fornell L, Rosenthal IM. Falsely elevated serum creatinine concentration in ketoacidosis. J Pediatr. 1985;107:562–564
  18. Levey AS, Coresh J, Greene T, et al. Chronic Kidney Disease Epidemiology Collaboration: Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  19. Cockcroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  20. Early Treatment of Diabetic Retinopathy Study Coordinating Center. Manual of Operations. Baltimore, MD: University of Maryland School of Medicine; 1980;
  21. Orchard TJ, Strandness DE. Report and recommendations of an international workshop sponsored by the AHA and ADA. Diabetes Care. 1993;16:1199–1209
  22. DCCT GroupSchumer M, Burton G, Burton C, Crum D, Pfeifer MA. Diabetic autonomic neuropathy, part I: Autonomic nervous system data analysis by a computerized central unit in a multicenter trial. Am J Med. 1988;85(suppl 5A):S137–S143
  23. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–1289
  24. Maser RE, Nielsen VK, Bass EB, et al. Measuring diabetic neuropathy (Assessment and comparison of clinical examination and quantitative sensory testing). Diabetes Care. 1989;12:270–275
  25. Arezzo JC. Quantitative Sensory Testing of Vibration Threshold Vibratron (II. Rationale and Methods). Clifton, NJ: Physitemp Instruments; 1993;
  26. Rubin MI, Bruck E, Rapoport M, Snively M, McKay H, Baumler A. Maturation of renal function in childhood: Clearance studies. J Clin Invest. 1949;28:1144–1162
  27. Arant BS. Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr. 1978;92:705–712
  28. Tucker BJ, Anderson CM, Thies RS, Collins RC, Blantz RC. Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int. 1992;42:1160–1168
  29. Tucker BJ, Mendonca MM, Blantz RC. Contrasting effects of acute insulin infusion on renal function in awake nondiabetic and diabetic rats. J Am Soc Nephrol. 1993;3:1686–1693
  30. Inishi Y, Okuda T, Arakawa T, Kurokawa K. Insulin attenuates intracellular calcium responses and cell contraction caused by vasoactive agents. Kidney Int. 1994;45:1318–1325
  31. Rabkin R, Kitaji J. Renal metabolism of peptide hormones. Miner Electrolyte Metab. 1983;9:212–226
  32. Ellis D, Forrest KY-Z, Erbey J, Orchard TJ. Urinary measurement of transforming growth factor-β and type IV collagen as new markers of renal injury: Application in diabetic nephropathy. Clin Chem. 1998;44:950–956
  33. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M International Diabetic Nephropathy Study Group. The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes. 2005;54:2164–2171
  34. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? (Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study). Kidney Int. 2002;62:963–970
  35. Yip J, Mattock M, Sethi M, Morocutti A, Viberti G. Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria. Lancet. 1993;341:369–370
  36. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet. 1993;342:883–887
  37. MacIsaac RJ, Jerums G, Cooper ME. New insights into the significance of microalbuminuria. Curr Opin Nephrol Hypertens. 2004;13:83–91
  38. Hovind P, Tarnow L, Rossing P, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: Inception cohort study. BMJ. 2004;328:1105–1108
  39. Rossing P, Hougaard P, Parving HH. Progression of microalbuminuria in type 1 diabetes: Ten-year prospective observational study. Kidney Int. 2005;68:1446–1450
  40. Lane PH, Steffes MW, Mauer SM. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes. 1992;41:581–586
  41. Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: An indicator of more advanced glomerular lesions. Diabetes. 2003;52:1036–1040
  42. Fioretto P, Mauer M, Brocco E, et al. Pattern of renal injury in NIDDM patients with microalbuminuria. Diabetologia. 1996;39:1669–1676
  43. Mazzucco G, Bertani T, Fortunato M, et al. Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies. Am J Kidney Dis. 2002;39:713–720
  44. MacIsaac RJ, Panagiotopoulos S, McNeil KJ, et al. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?. Diabetes Care. 2006;29:1560–1566
  45. Niskanen LK, Penttila I, Parviainen M, Uusitupa MI. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care. 1996;19:486–493
  46. Davis TM, Stratton IM, Fox CJ, Holman RR, Turner RC. U.K. Prospective Diabetes Study 22 (Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM). Diabetes Care. 1997;20:1435–1441
  47. Spijkerman AM, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: The Hoorn screening study. Diabetes Care. 2003;26:2604–2608
  48. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14:469–477
  49. Tapp RJ, Shaw JE, Zimmet PZ, et al. Albuminuria is evident in the early stages of diabetes onset: Results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis. 2004;44:792–798
  50. Ellis D, Lloyd C, Becker DJ, Forrest KY, Orchard TJ. The changing course of diabetic nephropathy: Low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. Am J Kidney Dis. 1996;27:809–818
  51. Tsalamandris C, Allen TJ, Gilbert RE, et al. Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes. 1994;43:649–655

 Originally published online as doi:10.1053/j.ajkd.2007.08.005 on October 3, 2007.

PII: S0272-6386(07)01141-9

doi: 10.1053/j.ajkd.2007.08.005

American Journal of Kidney Diseases
Volume 50, Issue 5 , Pages 721-732 , November 2007

Article Tools

* Image Usage & Resolution